Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 434

1.

Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: results of an international practice survey from ESCMID Fungal Infection Study Group and Study Group for Infections in Compromised Hosts, and European Confederation of Medical Mycology.

Rammaert B, Puyade M, Cornely OA, Seidel D, Grossi P, Husain S, Picard C, Lass-Flörl C, Manuel O, Le Pavec J, Lortholary O; SCEDO-LUNG collaborative group.

Transpl Infect Dis. 2019 Jul 8:e13141. doi: 10.1111/tid.13141. [Epub ahead of print]

PMID:
31283872
2.

Recent advances in managing HIV-associated cryptococcal meningitis.

Boyer-Chammard T, Temfack E, Alanio A, Jarvis JN, Harrison TS, Lortholary O.

F1000Res. 2019 May 28;8. pii: F1000 Faculty Rev-743. doi: 10.12688/f1000research.17673.1. eCollection 2019. Review.

3.

Defining standards of CARE for invasive fungal diseases in solid organ transplant patients.

Garcia-Vidal C, Carratalà J, Lortholary O.

J Antimicrob Chemother. 2019 Mar 1;74(Supplement_2):ii16-ii20. doi: 10.1093/jac/dkz039.

PMID:
31222312
4.

Remission of chronic acne fulminans and severe hidradenitis suppurativa with targeted antibiotherapy.

Duchatelet S, Join-Lambert O, Delage M, Miskinyte S, Guet-Revillet H, Lam T, Coignard-Biehler H, Ungeheuer MN, Chatenoud L, Lortholary O, Nassif X, Hovnanian A, Nassif AS.

JAAD Case Rep. 2019 Jun 8;5(6):525-528. doi: 10.1016/j.jdcr.2019.04.001. eCollection 2019 Jun. No abstract available.

5.

One year mortality outcomes from the ACTA trial of cryptococcal meningitis treatment in Malawi.

Kanyama C, Molloy SF, Chan AK, Lupiya D, Chawinga C, Adams J, Bright P, Lalloo DG, Heyderman RS, Lortholary O, Jaffar S, Loyse A, van Oosterhout JJ, Hosseinipour MC, Harrison TS.

Clin Infect Dis. 2019 Jun 1. pii: ciz454. doi: 10.1093/cid/ciz454. [Epub ahead of print]

PMID:
31155650
6.

Teaching NeuroImages: Aspergillosis-induced vasculitis presenting as ischemic stroke in an immunocompetent patient.

Lebeaux D, Klein I, Garcia G, Bruneel F, Pico F, Lortholary O.

Neurology. 2019 May 28;92(22):e2618-e2619. doi: 10.1212/WNL.0000000000007575. No abstract available.

PMID:
31133570
7.

Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, MMAS, and MCAS.

Lemal R, Fouquet G, Terriou L, Vaes M, Livideanu CB, Frenzel L, Barete S, Canioni D, Lhermitte L, Rossignol J, Arock M, Dubreuil P, Lortholary O, Hermine O.

J Allergy Clin Immunol Pract. 2019 Apr 5. pii: S2213-2198(19)30322-8. doi: 10.1016/j.jaip.2019.03.039. [Epub ahead of print]

PMID:
30954641
8.

Travel-related health events and their risk factors in HIV-infected sub-Saharan migrants living in France and visiting their native country: The ANRS VIHVO cohort study.

Pistone T, Ouattara E, Gabillard D, Lele N, Duvignaud A, Cordel H, Malvy D, Bouchaud O, Abgrall S; ANRS VIHVO Study Group.

Travel Med Infect Dis. 2019 May - Jun;29:40-47. doi: 10.1016/j.tmaid.2019.03.010. Epub 2019 Apr 2.

9.

Fulminant arterial vasculitis as an unusual complication of disseminated staphylococcal disease due to the emerging CC1 methicillin-susceptible Staphylococcus aureus clone: a case report.

Vidal C, Moulin F, Nassif X, Galmiche L, Borgel D, Charbit A, Picard C, Mira JP, Lortholary O, Jamet A, Toubiana J.

BMC Infect Dis. 2019 Apr 3;19(1):302. doi: 10.1186/s12879-019-3933-3.

10.

AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study.

Ponatshego PL, Lawrence DS, Youssouf N, Molloy SF, Alufandika M, Bango F, Boulware DR, Chawinga C, Dziwani E, Gondwe E, Hlupeni A, Hosseinipour MC, Kanyama C, Meya DB, Mosepele M, Muthoga C, Muzoora CK, Mwandumba H, Ndhlovu CE, Rajasingham R, Sayed S, Shamu S, Tsholo K, Tugume L, Williams D, Maheswaran H, Shiri T, Boyer-Chammard T, Loyse A, Chen T, Wang D, Lortholary O, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN, Niessen LW.

BMJ Open. 2019 Apr 1;9(4):e026288. doi: 10.1136/bmjopen-2018-026288.

11.

Spectrum of Pulmonary Aspergillosis in Hyper-IgE Syndrome with Autosomal-Dominant STAT3 Deficiency.

Duréault A, Tcherakian C, Poiree S, Catherinot E, Danion F, Jouvion G, Bougnoux ME, Mahlaoui N, Givel C, Castelle M, Picard C, Chansdesris MO, Lortholary O, Lanternier F; French Mycoses Study Group.

J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):1986-1995.e3. doi: 10.1016/j.jaip.2019.02.041. Epub 2019 Mar 13.

PMID:
30878710
12.

Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa.

Chen T, Mwenge L, Lakhi S, Chanda D, Mwaba P, Molloy SF, Gheorghe A, Griffiths UK, Heyderman RS, Kanyama C, Kouanfack C, Mfinanga S, Chan AK, Temfack E, Kivuyo S, Hosseinipour MC, Lortholary O, Loyse A, Jaffar S, Harrison TS, Niessen LW; ACTA Trial Team.

Clin Infect Dis. 2019 Mar 13. pii: ciy971. doi: 10.1093/cid/ciy971. [Epub ahead of print]

PMID:
30863852
13.

Why are so many cases of invasive aspergillosis missed?

Danion F, Rouzaud C, Duréault A, Poirée S, Bougnoux ME, Alanio A, Lanternier F, Lortholary O.

Med Mycol. 2019 Apr 1;57(Supplement_2):S94-S103. doi: 10.1093/mmy/myy081. Review.

PMID:
30816963
14.

Addition of flucytosine to fluconazole for the treatment of cryptococcal meningitis in Africa: a multi-country cost-effectiveness analysis.

Shiri T, Loyse A, Mwenge L, Chen T, Lakhi S, Chanda D, Mwaba P, Molloy SF, Heyderman R, Kanyama C, Hosseinipour MC, Kouanfack C, Temfack E, Mfinanga S, Kivuyo S, Chan AK, Jarvis JN, Lortholary O, Jaffar S, Niessen LW, Harrison TS.

Clin Infect Dis. 2019 Feb 28. pii: ciz163. doi: 10.1093/cid/ciz163. [Epub ahead of print]

PMID:
30816418
15.

Salvage Strategy for Long-Term Central Venous Catheter-Associated Staphylococcus aureus Infections in Children.

Alby-Laurent F, Lambe C, Ferroni A, Salvi N, Lebeaux D, Le Gouëz M, Castelle M, Moulin F, Nassif X, Lortholary O, Chalumeau M, Toubiana J.

Front Pediatr. 2019 Jan 25;6:427. doi: 10.3389/fped.2018.00427. eCollection 2018.

16.

Genetic diagnosis of primary immunodeficiencies: A survey of the French national registry.

Mahlaoui N, Picard C, Bach P, Costes L, Courteille V, Ranohavimparany A, Alcaïs A, Jais JP, Fischer A; CEREDIH French PID study group.

J Allergy Clin Immunol. 2019 Apr;143(4):1646-1649.e10. doi: 10.1016/j.jaci.2018.12.994. Epub 2019 Jan 9. No abstract available.

PMID:
30639347
17.

Baseline graft status is a critical predictor of kidney graft failure after diarrhoea.

Devresse A, Morin L, Aulagnon F, Taupin JL, Scemla A, Lanternier F, Aubert O, Aidoud AA, Lebreton X, Sberro-Soussan R, Snanoudj R, Amrouche L, Tinel C, Martinez F, Bererhi L, Anglicheau D, Lortholary O, Legendre C, Avettand-Fenoel V, Zuber J.

Nephrol Dial Transplant. 2019 Jan 3. doi: 10.1093/ndt/gfy386. [Epub ahead of print]

PMID:
30608553
18.

Understanding Pathogenesis and Care Challenges of Immune Reconstitution Inflammatory Syndrome in Fungal Infections.

Dellière S, Guery R, Candon S, Rammaert B, Aguilar C, Lanternier F, Chatenoud L, Lortholary O.

J Fungi (Basel). 2018 Dec 17;4(4). pii: E139. doi: 10.3390/jof4040139. Review.

19.

Progressive Multifocal Leukoencephalopathy in Primary Immunodeficiencies.

Hadjadj J, Guffroy A, Delavaud C, Taieb G, Meyts I, Fresard A, Streichenberger N, L'Honneur AS, Rozenberg F, D'Aveni M, Aguilar C, Rosain J, Picard C, Mahlaoui N, Lecuit M, Hermine O, Lortholary O, Suarez F.

J Clin Immunol. 2019 Jan;39(1):55-64. doi: 10.1007/s10875-018-0578-8. Epub 2018 Dec 14.

PMID:
30552536
20.

Disseminated Spiroplasma apis Infection in Patient with Agammaglobulinemia, France.

Etienne N, Bret L, Le Brun C, Lecuyer H, Moraly J, Lanternier F, Hermine O, Ferroni A, Lecuit M, Pereyre S, Beven L, Lortholary O.

Emerg Infect Dis. 2018 Dec;24(12):2382-2386. doi: 10.3201/eid2412.180567.

Supplemental Content

Loading ...
Support Center